CVSVSENVB• 12 Months (Normalized)
CVS vs ENVB (CVS Health Corporation vs Enveric Biosciences Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CVS Performance $95.49
+29.99%
CVS Health Corporation
Normalized Baseline0.00%
ENVB Performance $1.46
-87.06%
Enveric Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin CVS LEADS
+117.05%
CVS outperforming by 117.05%
CVSENVB
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CVS ENVB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | CVS Price | CVS Gain (%) | ENVB Price | ENVB Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $95.49 | +29.99% | $1.46 | -87.06% | +117.05% |
| Sep 11, 2026 | $94.66 | +28.86% | $1.42 | -87.41% | +116.27% |
| Sep 10, 2026 | $95.29 | +29.72% | $1.46 | -87.06% | +116.78% |
| Sep 09, 2026 | $95.38 | +29.84% | $1.46 | -87.10% | +116.94% |
| Sep 08, 2026 | $96.07 | +30.78% | $1.42 | -87.41% | +118.19% |
| Sep 04, 2026 | $96.74 | +31.69% | $1.39 | -87.68% | +119.37% |
| Sep 03, 2026 | $97.20 | +32.32% | $1.44 | -87.23% | +119.55% |
| Sep 02, 2026 | $97.23 | +32.36% | $1.44 | -87.23% | +119.59% |
| Sep 01, 2026 | $97.60 | +32.86% | $1.37 | -87.85% | +120.71% |
| Aug 31, 2026 | $93.91 | +27.84% | $1.37 | -87.85% | +115.69% |
| Aug 28, 2026 | $93.06 | +26.68% | $1.37 | -87.85% | +114.53% |
| Aug 27, 2026 | $92.92 | +26.49% | $1.37 | -87.85% | +114.34% |
| Aug 26, 2026 | $94.32 | +28.40% | $1.37 | -87.85% | +116.25% |
| Aug 25, 2026 | $92.90 | +26.46% | $1.46 | -87.06% | +113.52% |
| Aug 24, 2026 | $94.11 | +28.11% | $1.41 | -87.50% | +115.61% |
Page 1 of 17